Two Seas Capital LP - Significant Ownership

Signature - Title
/s/ Sina Toussi - Sina Toussi/Managing Member of Two Seas Capital GP LLC, its general partner
Location
Rye, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Two Seas Capital LP.

Significant Ownership of Two Seas Capital LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
OMEX ODYSSEY MARINE EXPLORATION INC Common Stock, par value $0.0001 per share 9.99% $9.92M $3.76M 5.08M +61.2% Two Seas Capital LP Sep 30, 2025
GCI Gannett Co., Inc. Common Stock, par value $0.01 per share 9.6% $58.6M $12.2M 14.2M +26.3% Two Seas Capital LP Sep 30, 2025
CORZ Core Scientific, Inc. Common Stock, par value $0.00001 per share 8% $513M $133M 24.7M +34.9% Two Seas Capital LP Nov 13, 2025
CLMT Calumet, Inc. Common Stock, par value $0.01 per share 7.8% $123M $41.2M 6.75M +50.1% Two Seas Capital LP Sep 30, 2025
INDV INDIVIOR PLC Ordinary Shares, $0.50 nominal value per share 7.4% $223M -$25.9M 9.25M -10.4% Two Seas Capital LP Nov 3, 2025
AVDL Avadel Pharmaceuticals plc Ordinary Shares, nominal value $0.01 per share 6.4% $91.2M $17.9M 6.16M +24.4% Two Seas Capital LP Jun 30, 2025
ABUS Arbutus Biopharma Corporation Common Shares, without par value 5.4% $38.3M 10.4M Two Seas Capital LP Jun 30, 2025
MDRX Veradigm Inc. Common Stock, par value $0.01 per share 5.3% $27.4M 5.82M Two Seas Capital LP Sep 30, 2025
ESPR Esperion Therapeutics, Inc. Common Stock, par value $0.001 per share 4.7% $25.8M -$544K 9.75M -2.06% Two Seas Capital LP Sep 30, 2025
ADAP Adaptimmune Therapeutics PLC Ordinary Shares, par value GBP 0.001 per share 0% $0 -$17.6M 0 -100% Two Seas Capital LP Sep 30, 2025

Schedules 13D/G Reported by Two Seas Capital LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.